Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma — Stella

Home/Relapsed/Refractory Multiple Myeloma (RRMM)/Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

View on ClinicalTrials.gov

Recruiting

Back to Relapsed/Refractory Multiple Myeloma (RRMM) trials

Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

Trial locations(1 site)

China

ShanxiBethuneH, Taiyuan, Shanxi

Key details

Sponsor

Shanxi Bethune Hospital

Enrollment target

~48 participants

Started

November 2025

Primary completion

November 2026

Age range

18 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.